Multiple Myeloma

Researchers have uncovered a new reason CAR-T cell therapy fails in some patients, fueling new strategies to improve the treatment's outcome.

Dr. Joselle Cook explains how recent advances in treatment are helping people with multiple myeloma live longer.

After receiving CAR-T cell therapy at Mayo Clinic, Welsh-born John Cadwallader achieved remission and found new hope. He now receives care in the U.K. and is monitored by Mayo in the U.S. and London.

Mayo Clinic's Advanced Care at Home program helped David Elder recover at home from a bone marrow transplant to treat his multiple myeloma.

Learn about CAR-T cell therapy and research at Mayo Clinic to reduce its side effects and expand its use beyond blood cancers.

Researchers find that a gene may play a role in causing people with telomere biology disorders to have a high risk of developing blood cancer.

Dr. Mohamed Kharfan Dabaja discusses who is eligible for CAR-T cell therapy, the treatment process and its potential side effects.

Hematologist Dr. Yi Lin discusses the use of immunotherapies and other novel approaches to treating multiple myeloma.

Dr. Reona Sakemura is researching treatment resistance mechanisms in multiple myeloma to make immunotherapy more effective.

Veronica Ciudad-Real shares her experience with multiple myeloma treatment as an international patient at Mayo Clinic.